ArticleContraception2018
Family planning providers' role in offering PrEP to women.
Article in Contraception, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 45 citations in OpenAlex.
- Acceptability of an intravaginal ring for simultaneously preventing HIV infection and pregnancy: Qualitative findings of the Kisumu Combined Ring Study, 2019.Contemporary clinical trials · 2022Trial
- Current Contraceptive Practices and Pre-exposure Prophylaxis Modality Preferences among Black and Non-Black Women in the United States: Implications for Bundled Messaging.Archives of sexual behavior · 2026Article
- Barriers and Facilitators of Oral PrEP Uptake Against HIV Among Selected Priority Populations: A Global Perspective.Current HIV/AIDS reports · 2026Review
- Black women's preferences regarding use of mHealth for sexual health support in Chicago, a cross-sectional study.PLOS digital health · 2025Article
- Article
- Experiences, Attitudes and Preferences of Postpartum Cisgender Women for HIV Prevention and Pre-Exposure Prophylaxis Education during Routine Postpartum Care.AIDS and behavior · 2025Article
- Increasing Engagement in Human Immunodeficiency Virus Prevention Among Cisgender Women in New York City With Sexual Health Self-Testing Kits: A MaxDiff Analysis.Sexually transmitted diseases · 2025Article
- Integrating HIV prevention with family planning services for adolescent girls and young women in Uganda: perspectives of adolescent girls and young women, health care providers, and policymakers.Frontiers in reproductive health · 2025Article
- Implementation strategies to support pre-exposure prophylaxis for HIV prevention care for cisgender women in federally-funded family planning clinics in Atlanta, Georgia.Frontiers in reproductive health · 2025Article
- Impact of the COVID-19 Pandemic on the PrEP Cascade at Two Veterans Affairs Healthcare Systems.AIDS and behavior · 2024Article
- Implementation of an Educational Intervention to Improve HIV Pre-Exposure Prophylaxis Services for Women in an Urban Sexual Health Clinic.AIDS patient care and STDs · 2023Article
- Integrating pre-exposure prophylaxis of HIV infection into family planning services: a scoping review.BMJ sexual & reproductive health · 2023Article
- Barriers to PrEP uptake among Black female adolescents and emerging adults.Preventive medicine reports · 2023Article
- Reimagining Preexposure Prophylaxis Provision for Women in the United States.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022Article
- Knowledgeable, aware / interested: Young black women's perceptions of pre-exposure prophylaxis.Frontiers in reproductive health · 2022Article
- Introduction and integration of PrEP and sexual and reproductive health services for young people: Health provider perspectives from South Africa.Frontiers in reproductive health · 2022Article
- Lessons Learned from Longer Acting Reversible Contraception Applied to Longer Acting HIV Prevention Technologies.Current HIV/AIDS reports · 2021Review
- Patient-Led Decision-Making for HIV Preexposure Prophylaxis.Current HIV/AIDS reports · 2021Review
- Integration of HIV Prevention With Sexual and Reproductive Health Services: Evidence for Contraceptive Options and HIV Outcomes Study Experience of Integrating Oral Pre-exposure HIV Prophylaxis in Family Planning Services in Lusaka, Zambia.Frontiers in reproductive health · 2021Article
- Health Care Providers as Agents of Change: Integrating PrEP With Other Sexual and Reproductive Health Services for Adolescent Girls and Young Women.Frontiers in reproductive health · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
Abstract
Pre-exposure prophylaxis (PrEP) provides a radically different HIV prevention option for women. Not only is PrEP the first discrete, woman-controlled method that is taken in advance of exposure, but it is both safe and highly effective, offering over 90% protection if taken daily. While multiple modalities of PrEP are in development ranging from vaginal rings to injectables and implants, only PrEP with oral tenofovir/emtricitabine is currently FDA-approved. Family planning clinics provide key access points for many women to learn about and obtain PrEP. By incorporating PrEP services into family planning care, family planning providers have the opportunity to meet women's expectations, ensure women are aware of and offered comprehensive HIV prevention options, and reverse emerging disparities in PrEP access. Despite real and perceived barriers to integrating PrEP into family planning care, providing PrEP services, ranging from education to onsite provision, is not only possible but an important component of providing high-quality sexual and reproductive healthcare to women. Lessons learned from early adopters will help guide those in family planning settings initiating or enhancing PrEP services.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.